- Home
- GLYC vs LRE Comparison
GLYC vs LRE Comparison
Compare GLYC & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLYC
- LRE
- Stock Information
- Founded
- GLYC 2003
- LRE 2001
- Country
- GLYC United States
- LRE Japan
- Employees
- GLYC N/A
- LRE N/A
- Industry
- GLYC Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- GLYC Health Care
- LRE
- Exchange
- GLYC Nasdaq
- LRE Nasdaq
- Market Cap
- GLYC 15.9M
- LRE 18.3M
- IPO Year
- GLYC 2014
- LRE 2023
- Fundamental
- Price
- GLYC $0.19
- LRE $1.35
- Analyst Decision
- GLYC Hold
- LRE
- Analyst Count
- GLYC 3
- LRE 0
- Target Price
- GLYC N/A
- LRE N/A
- AVG Volume (30 Days)
- GLYC 228.8K
- LRE 2.6K
- Earning Date
- GLYC 05-08-2025
- LRE 01-01-0001
- Dividend Yield
- GLYC N/A
- LRE N/A
- EPS Growth
- GLYC N/A
- LRE N/A
- EPS
- GLYC N/A
- LRE 0.29
- Revenue
- GLYC N/A
- LRE $117,804,154.00
- Revenue This Year
- GLYC N/A
- LRE N/A
- Revenue Next Year
- GLYC N/A
- LRE N/A
- P/E Ratio
- GLYC N/A
- LRE $4.20
- Revenue Growth
- GLYC N/A
- LRE 8.82
- 52 Week Low
- GLYC $0.14
- LRE $1.10
- 52 Week High
- GLYC $3.02
- LRE $13.76
- Technical
- Relative Strength Index (RSI)
- GLYC 31.68
- LRE 50.02
- Support Level
- GLYC $0.19
- LRE $1.19
- Resistance Level
- GLYC $0.22
- LRE $1.26
- Average True Range (ATR)
- GLYC 0.02
- LRE 0.04
- MACD
- GLYC -0.01
- LRE 0.03
- Stochastic Oscillator
- GLYC 16.67
- LRE 93.75
About GLYC GlycoMimetics Inc.
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.